Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Targeted sequencing of Parkinson’s disease loci genes highlights SYT11, FGF20 and other associations

View ORCID ProfileUladzislau Rudakou, Eric Yu, Lynne Krohn, Jennifer A. Ruskey, Farnaz Asayesh, Yves Dauvilliers, Dan Spiegelman, Lior Greenbaum, Stanley Fahn, Cheryl H. Waters, Nicolas Dupré, Guy A. Rouleau, Sharon Hassin-Baer, Edward A. Fon, Roy N. Alcalay, Ziv Gan-Or
doi: https://doi.org/10.1101/2020.05.29.20116111
Uladzislau Rudakou
1Department of Human Genetics, McGill University, Montréal, QC, H3A 1A1, Canada
2Montreal Neurological Institute, McGill University, Montréal, QC, H3A 1A1, Canada
BSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Uladzislau Rudakou
Eric Yu
1Department of Human Genetics, McGill University, Montréal, QC, H3A 1A1, Canada
2Montreal Neurological Institute, McGill University, Montréal, QC, H3A 1A1, Canada
BSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lynne Krohn
1Department of Human Genetics, McGill University, Montréal, QC, H3A 1A1, Canada
2Montreal Neurological Institute, McGill University, Montréal, QC, H3A 1A1, Canada
BSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer A. Ruskey
2Montreal Neurological Institute, McGill University, Montréal, QC, H3A 1A1, Canada
3Department of Neurology and Neurosurgery, McGill University, Montréal, QC, H3A 1A1, Canada
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Farnaz Asayesh
2Montreal Neurological Institute, McGill University, Montréal, QC, H3A 1A1, Canada
3Department of Neurology and Neurosurgery, McGill University, Montréal, QC, H3A 1A1, Canada
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yves Dauvilliers
4National Reference Center for Narcolepsy, Sleep Unit, Department of Neurology, Gui-de-Chauliac Hospital, CHU Montpellier, University of Montpellier, Inserm U1061, Montpellier, France
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dan Spiegelman
2Montreal Neurological Institute, McGill University, Montréal, QC, H3A 1A1, Canada
3Department of Neurology and Neurosurgery, McGill University, Montréal, QC, H3A 1A1, Canada
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lior Greenbaum
5The Danek Gertner Institute of Human Genetics, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel
6The Joseph Sagol Neuroscience Center, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel
7Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stanley Fahn
8Department of Neurology, College of Physicians and Surgeons, Columbia University Medical Center, New York, NY 10032, USA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cheryl H. Waters
8Department of Neurology, College of Physicians and Surgeons, Columbia University Medical Center, New York, NY 10032, USA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicolas Dupré
9Division of Neurosciences, CHU de Québec, Université Laval, Québec City, QC, G1V 0A6, Canada
10Department of Medicine, Faculty of Medicine, Université Laval, Québec City, QC, G1V 0A6, Canada
MD, FRCP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guy A. Rouleau
1Department of Human Genetics, McGill University, Montréal, QC, H3A 1A1, Canada
2Montreal Neurological Institute, McGill University, Montréal, QC, H3A 1A1, Canada
3Department of Neurology and Neurosurgery, McGill University, Montréal, QC, H3A 1A1, Canada
MD, PhD, FRCPC, FRSC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sharon Hassin-Baer
7Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
11Department of Neurology, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel
12Movement Disorders Institute, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edward A. Fon
2Montreal Neurological Institute, McGill University, Montréal, QC, H3A 1A1, Canada
3Department of Neurology and Neurosurgery, McGill University, Montréal, QC, H3A 1A1, Canada
MD, FRCPC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roy N. Alcalay
8Department of Neurology, College of Physicians and Surgeons, Columbia University Medical Center, New York, NY 10032, USA
13Taub Institute for Research on Alzheimer’s Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University Medical Center, New York, NY 10032, USA
MD, MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ziv Gan-Or
1Department of Human Genetics, McGill University, Montréal, QC, H3A 1A1, Canada
2Montreal Neurological Institute, McGill University, Montréal, QC, H3A 1A1, Canada
3Department of Neurology and Neurosurgery, McGill University, Montréal, QC, H3A 1A1, Canada
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ziv.gan-or{at}mcgill.ca
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Genome-wide association studies (GWAS) have identified numerous loci associated with Parkinson’s disease. The specific genes and variants that drive the associations within the vast majority of these loci are unknown. We aimed to perform a comprehensive analysis of selected genes to determine the potential role of rare and common genetic variants within these loci. We fully sequenced 32 genes from 25 loci previously associated with Parkinson’s disease in 2,657 patients and 3,647 controls from three cohorts. Capture was done using molecular inversion probes targeting the exons, exon-intron boundaries and untranslated regions (UTRs) of the genes of interest, followed by sequencing. Quality control was performed to include only high-quality variants. We examined the role of rare variants (minor allele frequency < 0.01) using optimized sequence Kernel association tests (SKAT-O). The association of common variants was estimated using regression models adjusted for age, sex and ethnicity as required in each cohort, followed by a meta-analysis. After Bonferroni correction, we identified a burden of rare variants in SYT11, FGF20 and GCH1 associated with Parkinson’s disease. Nominal associations were identified in 21 additional genes. Previous reports suggested that the SYT11 GWAS association is driven by variants in the nearby GBA gene. However, the association of SYT11 was mainly driven by a rare 3’ UTR variant (rs945006601) and was independent of GBA variants (p=5.23E-05 after exclusion of all GBA variant carriers). The association of FGF20 was driven by a rare 5’ UTR variant (rs1034608171) located in the promoter region. The previously reported association of GCH1 with Parkinson’s Disease is driven by rare nonsynonymous variants, some of which are known to cause dopamine-responsive dystonia. We also identified two LRRK2 variants, p.Arg793Met and p.Gln1353Lys, in ten and eight controls, respectively, but not in patients. We identified common variants associated with Parkinson’s disease in MAPT, TMEM175, BST1, SNCA and GPNMB which are all in strong linkage disequilibrium (LD) with known GWAS hits in their respective loci. A common coding PM20D1 variant, p.Ile149Val, was nominally associated with reduced risk of Parkinson’s disease (OR 0.73, 95% CI 0.60-0.89, p=1.161E-03). This variant is not in LD with the top GWAS hits within this locus and may represent a novel association. These results further demonstrate the importance of fine mapping of GWAS loci, and suggest that SYT11, FGF20, and potentially PM20D1, BST1 and GPNMB should be considered for future studies as possible Parkinson’s disease-related genes.

Competing Interest Statement

Ziv Gan-Or has received consulting fees from Lysosomal Therapeutics Inc., Idorsia, Prevail Therapeutics, Denali, Ono Therapeutics, Deerfield and Inception Sciences (now Ventus). None of these companies were involved in any parts of preparing, drafting and publishing this review. Cheryl H. Waters disclosed the following: Research support (Biogen, Roche, Sanofi); consulting fees (Acorda, Amneal, Impel, Kyowa, Mitsubishi, and Neurocrine); speaker honoraria (Acadia, Acorda, Adamas, Amneal, and US WorldMeds)

Funding Statement

This work was financially supported by grants from the Michael J. Fox Foundation, the Canadian Consortium on Neurodegeneration in Aging (CCNA), the Canada First Research Excellence Fund (CFREF), awarded to McGill University for the Healthy Brains for Healthy Lives initiative (HBHL), and Parkinson Canada. The Columbia University cohort is supported by the Parkinson s Foundation, the National Institutes of Health (K02NS080915, and UL1 TR000040) and the Brookdale Foundation.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

McGill University Health Center Research Ethics Board - MUHC REB Columbia University Sheba Medical Center

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Additional author was included. Added page 11 line 21 - page 12 line 2 to clarify the comparison of young and elderly controls. Added a section about potential genetic heterogeneity due to different ethnical origins to the limitations , page 21 lines 15-22. Added clarifications for the difference in results seen in 30x coverage vs. 50x coverage : page 13 line 18 - page 14 line 3; page 14 lines 11-16. Added a brief discussion about the issue of using different depths of coverage : page 20 line 20 - page 21 line 7. Modified the text to better explain the selection of target genes : page 9 lines 14-20. Added a section to better explain the identification of the main drivers of the associations : age 12 lines 8-12. Added the number of LRRK2 G2019S carriers that were removed for the analysis : page 15 lines 1-3. Added a section about FDR correction In the Methods: page 12 lines 6-8. Added information on the validations of significant results using another genotyping technology: rare SYT11 variants page 13 line 18 - page 14 line 2, rare FGF20 variants page 14 lines 11-16, common variants in page 20 line 20 - page 21 line 3. Corrected the text related to LD of identified SYT11 variant with GBA page 14 lines 3-10. Figure 3 was moved to the supplementary materials. Supplemental files updated

Data Availability

Anonymized data is available upon request by any qualified investigator.

  • Abbreviations

    AJ
    Ashkenazi Jewish
    CADD
    Combined Annotation Dependent Depletion
    CI
    confidence interval
    CNS
    central nervous system
    DOPA
    dihydroxyphenylalanine
    DP
    depth of coverage
    eQTL
    expression quantitative trait loci
    GATK
    Genome Analysis Toolkit
    GnomAD
    Genome Aggregation Database
    GTEx
    Genotype-tissue expression
    GWAS
    Genome-wide association study
    hg19
    human genome version 19
    LD
    linkage disequilibrium
    LOF
    loss-of-function
    MAF
    minor allele frequency
    MIPs
    molecular inversion probes
    NS, Nonsyn
    non-synonymous
    OR
    odds ratio
    QC
    quality control
    REM
    Rapid Eye Movement
    SKAT-O
    optimized sequence kernel association test
    sQTL
    splicing quantitative trait loci
    UTR
    untranslated region
    yo
    years of age
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
    Back to top
    PreviousNext
    Posted September 25, 2020.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Targeted sequencing of Parkinson’s disease loci genes highlights SYT11, FGF20 and other associations
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Targeted sequencing of Parkinson’s disease loci genes highlights SYT11, FGF20 and other associations
    Uladzislau Rudakou, Eric Yu, Lynne Krohn, Jennifer A. Ruskey, Farnaz Asayesh, Yves Dauvilliers, Dan Spiegelman, Lior Greenbaum, Stanley Fahn, Cheryl H. Waters, Nicolas Dupré, Guy A. Rouleau, Sharon Hassin-Baer, Edward A. Fon, Roy N. Alcalay, Ziv Gan-Or
    medRxiv 2020.05.29.20116111; doi: https://doi.org/10.1101/2020.05.29.20116111
    Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    Targeted sequencing of Parkinson’s disease loci genes highlights SYT11, FGF20 and other associations
    Uladzislau Rudakou, Eric Yu, Lynne Krohn, Jennifer A. Ruskey, Farnaz Asayesh, Yves Dauvilliers, Dan Spiegelman, Lior Greenbaum, Stanley Fahn, Cheryl H. Waters, Nicolas Dupré, Guy A. Rouleau, Sharon Hassin-Baer, Edward A. Fon, Roy N. Alcalay, Ziv Gan-Or
    medRxiv 2020.05.29.20116111; doi: https://doi.org/10.1101/2020.05.29.20116111

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Neurology
    Subject Areas
    All Articles
    • Addiction Medicine (349)
    • Allergy and Immunology (668)
    • Allergy and Immunology (668)
    • Anesthesia (181)
    • Cardiovascular Medicine (2648)
    • Dentistry and Oral Medicine (316)
    • Dermatology (223)
    • Emergency Medicine (399)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
    • Epidemiology (12228)
    • Forensic Medicine (10)
    • Gastroenterology (759)
    • Genetic and Genomic Medicine (4103)
    • Geriatric Medicine (387)
    • Health Economics (680)
    • Health Informatics (2657)
    • Health Policy (1005)
    • Health Systems and Quality Improvement (985)
    • Hematology (363)
    • HIV/AIDS (851)
    • Infectious Diseases (except HIV/AIDS) (13695)
    • Intensive Care and Critical Care Medicine (797)
    • Medical Education (399)
    • Medical Ethics (109)
    • Nephrology (436)
    • Neurology (3882)
    • Nursing (209)
    • Nutrition (577)
    • Obstetrics and Gynecology (739)
    • Occupational and Environmental Health (695)
    • Oncology (2030)
    • Ophthalmology (585)
    • Orthopedics (240)
    • Otolaryngology (306)
    • Pain Medicine (250)
    • Palliative Medicine (75)
    • Pathology (473)
    • Pediatrics (1115)
    • Pharmacology and Therapeutics (466)
    • Primary Care Research (452)
    • Psychiatry and Clinical Psychology (3432)
    • Public and Global Health (6527)
    • Radiology and Imaging (1403)
    • Rehabilitation Medicine and Physical Therapy (814)
    • Respiratory Medicine (871)
    • Rheumatology (409)
    • Sexual and Reproductive Health (410)
    • Sports Medicine (342)
    • Surgery (448)
    • Toxicology (53)
    • Transplantation (185)
    • Urology (165)